IIFT for Pemphigoid

Last week, our team at AbBaltis focused on screening for Pemphigoid, a rare autoimmune disease, using the Indirect Immunofluorescence Test (IIFT)

🔬 Understanding Pemphigoid

Pemphigoid is a group of autoimmune blistering diseases that affect the skin and mucous membranes. The body’s immune system mistakenly attacks the proteins that hold skin cells together, leading to painful blisters and erosions. Accurate diagnosis is crucial for effective treatment, making early and precise detection essential.

🏥 The Role of IIFT in Autoimmune Disease Diagnosis

IIFT plays a critical role in the diagnosis of autoimmune diseases like Pemphigoid. By detecting specific autoantibodies in patient samples, IIFT allows for a detailed assessment of disease presence and progression. This test is a powerful tool in the diagnostic process, providing vital insights that guide treatment plans.

🎯 Our Commitment to Quality Control

At AbBaltis, our efforts in screening material are vital in identifying high-quality control materials, which are essential for ensuring accurate and reliable results in IIFT assays. Through careful development and optimization, we elevate the diagnostics process, helping labs achieve precise outcomes and supporting better patient care.

Stay tuned for more updates on how we apply similar rigor to ELISA and line blots, and how we customise our screening processes to meet our customers’ unique needs.

 Back to News